Thursday, May 17, 2018
12:00pm - 1:30pm Eastern time
1.5 CE Credits
Robert A. Stern, Ph.D.
Professor of Neurology, Neurosurgery, and Anatomy & Neurobiology
Clinical Core Director, BU Alzheimer’s Disease Center
Director of Clinical Research, BU CTE Center
Boston University School of Medicine
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease found in individuals with a history of exposure to repetitive head impacts (RHI), such as former American football players and boxers. Referred to as “punch drunk” or dementia pugilistica since the early 20th century, the term “CTE” has been used since the 1950s to describe the clinical and neuropathological changes seen in individuals with RHI exposure. However, it is only in the past 8-10 years that CTE has received increased attention due to a growing number of deceased former NFL players being diagnosed with the disease postmortem. The tremendous growth in media attention to CTE, however, has outpaced the growth in scientific understanding of CTE. As with other neurodegenerative diseases, at this time CTE can only be diagnosed by neuropathological examination. However, provisional clinical research diagnostic criteria have been proposed and studies are underway to develop neuroimaging and fluid biomarkers to detect and diagnose CTE during life. This webinar will provide an overview of what is currently known about CTE, as well as current and future directions in research.
After the webinar, participants will be able to:
- Describe the neuropathological and clinical features of chronic traumatic encephalopathy (CTE).
- Describe the possible fluid and neuroimaging biomarkers for CTE.
- Explain the current limitations of making a clinical diagnosis of CTE.
Target Audience: The target audience includes practicing neuropsychologists and clinical neuroscience researchers, as well as advanced trainees.
NAN members login and non-members create an account to:
Instructional Level: Intermediate
Registration closes 30 minutes prior to the live presentation.
received his Ph.D. in Clinical
Psychology from the University of Rhode Island. He completed his predoctoral
internship training under Dr. Edith Kaplan at the Boston VA Medical Center and
his post-doctoral fellowship at the University of North Carolina School of
Medicine. He is currently Professor of Neurology, Neurosurgery, and Anatomy
& Neurobiology at Boston University (BU) School of Medicine, where he is
also Director of the Clinical Core of the NIH-funded BU Alzheimer’s Disease
Center, and Director of Clinical Research for the BU Chronic Traumatic
Encephalopathy (CTE) Center. A major
focus of his research involves the long-term effects of repetitive head impacts
in athletes, including the neurodegenerative disease, CTE. He is the lead co-principal investigator of a
$16 million NIH grant for a multi-center, longitudinal study to develop methods
of diagnosing CTE during life as well as examining potential risk factors of
the disease. Dr. Stern’s other current major area of funded research involves
the diagnosis and treatment of Alzheimer’s disease. He has published on various
aspects of cognitive assessment and is the senior author of the Neuropsychological Assessment Battery (NAB),
as well as the Boston Qualitative Scoring
System for the Rey-Osterreith Complex Figure. He has received numerous NIH and other
national grants and he is a Fellow of both the NAN and the American
Neuropsychiatric Association. Dr. Stern has over 175 peer-reviewed
publications, is on several journal editorial boards, and is the co-editor of
two upcoming books: Sports Neurology
(part of the Handbook in Clinical Neurology series published by Elsevier), and The Oxford Handbook of Adult Cognitive
Disorders. He is a member of the medical advisory boards of several biotech/pharma
companies as well as the Mackey-White Health and Safety Committee of the NFL
Players Association and the Medical Scientific Committee for the NCAA
Student-Athlete Concussion Injury Litigation.